Magnetically powered 'nanosperm'; Inovio announces reverse stock split;

> Scientists have developed a propulsion system that moves synthetic "nanosperms," which could someday be employed for therapeutic uses, by using a weak oscillating magnetic field. Story

> Inovio Pharmaceuticals ($INO), maker of vaccines that contain DNA plasmids, announced that its reverse stock split will become effective on June 5. Release

> By removing certain genes of the malaria parasite Plasmodium, researchers at the nonprofit Seattle BioMed believe it could become a vaccine for the disease. Story

> Aprecia Pharmaceuticals, maker of the ZipDose platform, signed an agreement with commercialization outsourcing organization inVentiv Health as it prepares for its first NDA application. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.